<DOC>
	<DOCNO>NCT00117611</DOCNO>
	<brief_summary>The purpose study determine treatment anti-IgE antibody , Xolair ( omalizumab ) , improve objective subjective evidence chronic sinusitis .</brief_summary>
	<brief_title>Xolair Patients With Chronic Sinusitis</brief_title>
	<detailed_description>At basic level , sinusitis define inflammation line membrane paranasal sinus . Sinusitis affect age group , include 17 % people age 65 year . On basis national population survey insurance-reimbursement claim , sinusitis one common health problem U.S . Thus , year , billion dollar spend direct medical cost treatment enigmatic illness . Despite enormous cost problem , definite study treatment management . There data indicate intranasal steroid effective , recently Nasonex approve treatment nasal polyp . All treatment empirically base . There evidence IgE antibody play role chronic sinusitis . The investigator show total IgE level correlate severity sinusitis , assess CT scan . Staphylococcus enterotoxins cause local increase total IgE 50 % nasal polyp patient . Allergies occur frequently patient chronic sinusitis general population . Elevations total IgE show occur patient allergic fungal sinusitis level total IgE decrease successful treatment . Thus , investigator speculate IgE contribute significantly pathogenesis chronic sinusitis . The purpose study determine treatment anti-IgE antibody , Xolair , improve objective subjective evidence chronic sinusitis .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Anti-Idiotypic</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>Chronic sinusitis , define symptom great 12 week , despite treatment Paranasal sinus CT scan show evidence chronic sinusitis Positive skin RAST test inhalant allergen Serum total IgE 30 700 International Units/ml Body weight less 150 kg Impaired quality life , measure Rhinosinusitis Disability Index ( RSDI ) Women childbearing potential use contraception method ( ) ( birth control pill , Depo Provera , double barrier ) well woman breastfeed Known sensitivity Xolair Patients severe medical condition ( ) , opinion investigator , prohibit participation study ( heart , lung , kidney , neurological , oncologic liver disease ) Use investigational agent last 30 day No measurable disability RSDI Immunocompromised patient patient ciliary disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>chronic sinusitis</keyword>
</DOC>